New York State Common Retirement Fund’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,600	Closed	-$15.4K	–	3245
2025 Q1	$15.4K	Hold	12,600	–	–	﹤0.01%	3019
2024 Q4	$16.3K	Hold	12,600	–	–	﹤0.01%	3073
2024 Q3	$34.6K	Sell	12,600 -32,900	-72%	-$80.8K	﹤0.01%	2959
2024 Q2	$103K	Buy	+45,500	New	+$138K	﹤0.01%	2783
2021 Q3	–	Sell	-259	Closed	-$1K	–	3415
2021 Q2	$1K	Sell	259 -24,041	-99%	-$85.6K	﹤0.01%	3409
2021 Q1	$53K	Hold	24,300	–	–	﹤0.01%	3206
2020 Q4	$54K	Hold	24,300	–	–	﹤0.01%	3177
2020 Q3	$65K	Hold	24,300	–	–	﹤0.01%	3087
2020 Q2	$74K	Hold	24,300	–	–	﹤0.01%	3093
2020 Q1	$48K	Hold	24,300	–	–	﹤0.01%	2990
2019 Q4	$69K	Hold	24,300	–	–	﹤0.01%	3081
2019 Q3	$89K	Sell	24,300 -8,900	-27%	-$32.2K	﹤0.01%	3062
2019 Q2	$138K	Buy	+33,200	New	+$144K	﹤0.01%	2990
2016 Q1	–	Sell	-10,200	Closed	-$17K	–	3148
2015 Q4	$17K	Hold	10,200	–	–	﹤0.01%	3156
2015 Q3	$24K	Sell	10,200 -10,740	-51%	-$25.3K	﹤0.01%	3146
2015 Q2	$57K	Buy	20,940 +10,740	+105%	+$32.4K	﹤0.01%	3189
2015 Q1	$34K	Buy	+10,200	New	+$36.4K	﹤0.01%	2254